{"version":"1.0","type":"link","title":"Pan-RAF inhibitor exarafenib targets BRAF class II/III NSCLC and reveals ARAF-KSR1 resistance and combination strategies.","author_name":"Manabe T 외","author_url":"https://prs-insight.online/author/Manabe%20T","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/97394","thumbnail_width":1200,"thumbnail_height":630}